Ritivel

Early-stage AI workspace whose agents draft regulatory and medical-writing documents such as CTDs, CSRs, INDs, and BLAs.

Ritivel, founded in 2025 and headquartered in San Francisco, California, is an early-stage (Y Combinator W26) company building an AI-native workspace for regulatory and medical-writing teams, using language models tuned on life-sciences content to draft documents such as CTDs, CSRs, INDs, and BLAs with traceability to source data for human review. As a very small pre-seed company, its scale, longevity, and enterprise readiness should be assessed directly. Atlas found no vendor-held security certifications documented on its site; drafts are AI-generated and require medical-writer review.

Headquarters
San Francisco, United States
Founded
2025
Deployment options
cloud
Website
https://www.ritivel.com
LinkedIn
https://www.linkedin.com/company/ritivel-yc-w26

Categories

AI Use Cases

  • Regulatory Submission Authoring

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents Ritivel across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Biotech Startup, Mid-Size Biotech, Regulatory Affairs, Medical Affairs

Solution Scope — Documented

Natural Language Processing, Regulatory Submission Authoring

Company Viability — Partially documented

Pre-seed, Founded 2025

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which document types are supported in production today?
  • How does the workspace maintain traceability from generated text to source data?
  • How is our clinical data segregated and protected during generation?
  • What is the company's staffing, funding runway, and enterprise-support model?